Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism B2 receptor antagonists(Bradykinin B2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Craniocerebral Trauma | Preclinical | IL | 01 Sep 2000 |